ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,25
-0,79%
Dow Jones
40 211,72
0,53%
DAX
18 508,16
-0,49%
Brent Oil
83,555
-0,93%
Bitcoin
63 503,92
-2,08%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateHeureSourceTitreSymboleSociété
10/05/201213h00Business WireSpectrum Pharmaceuticals & Allos Therapeutics Announce Extension of Previously Announced Tender Offer For Shares of Allos The...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/05/201219h25Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/05/201219h14Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/05/201211h45ZacksAllos Narrows Loss, Awaits Takeover - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/05/201215h03Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/05/201200h57Business WireRobbins Geller Rudman & Dowd LLP Files Class Action Suit Against Allos Therapeutics, Inc.NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/04/201223h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/04/201222h18Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/04/201219h45ZacksBad News for Allos - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/04/201216h11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/04/201215h54Business WireAllos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN® in EuropeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/04/201222h59Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/04/201214h15Business WireSpectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos TherapeuticsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/04/201212h04Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/04/201212h04Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/04/201223h24Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/04/201223h11Edgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201217h26Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201214h15ZacksAllos Eyed by Spectrum Pharma - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/04/201211h06ZacksCompany News for April 9, 2012 - Corporate SummaryNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/04/201212h07Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201223h23Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201220h07Dow Jones NewsUPDATE: Amid Setback, Spectrum Pharma To Buy Allos For $206 MillionNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201216h28PR Newswire (US)Allos Therapeutics, Inc. (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum ...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201214h52PR Newswire (US)Block & Leviton LLP Investigates Allos Therapeutics, Inc. for Possible Breaches of Fiduciary Duties for Its Proposed Merger w...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/04/201213h00Business WireSpectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/03/201210h14ZacksZacks #1 Rank Additions for Friday - Tale of the TapeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/03/201212h03Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/03/201211h00ZacksAllos Upped to Outperform - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/03/201209h15ZacksAllos Narrows Loss - Analyst BlogNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Dernières Valeurs Consultées

NYSE
BERY
Berry Global
BIT
UB7DK3
Unicredit Bank
BIT
P22SO0
NLBNPIT22SO0 20241220 800
NASDAQ
SLAMU
Slam
BIT
UC6BFS
Unicredit Bank
LSE
0OG6
Seche Environnement
LSE
0CQ5
Societe Electrique De L'...
LSE
0OGM
Kupele Strbske Pleso As
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés